通过USP34介导的FOXC1的de-ubiquitination,BPTF促进质瘤的发展
Yanling Pan1, Feng Yuan1, Zhiren Lin1
1Department of Radiotherapy, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, Hainan Province, PR China.
大脑癌症的生长是由BPTF驱动的,这会影响FOXC1的稳定性. 准BPTF/FOXC1通路可能会抑制质瘤的发展并改善患者的治疗结果.
科学领域:
- 分子瘤学分子瘤学
- 癌症生物学 癌症生物学
- 神经瘤学神经瘤学
背景情况:
- 质瘤是最常见的恶性脑瘤,需要了解其分子驱动因素才能获得临床进展.
- 以前的研究已经确定了Bromodomain PHD指转录因子 (BPTF) 作为质瘤恶性瘤的促进者和预后不良的预测因子.
研究的目的:
- 阐明BPTF在质瘤发育中的下游调节机制.
- 为了研究叉头盒C1 (FOXC1) 在BPTF介导的质瘤进展中的作用.
- 探索BPTF/FOXC1轴作为治疗点的潜力.
主要方法:
- 使用西部斑块和免疫组织化学进行蛋白质表达分析.
- 细胞测试 (CCK8,流细胞计,scratch,Transwell) 来评估增殖,亡和迁移.
- 生物化学测试 (免疫沉,西部斑) 确定蛋白质相互作用和无处不在状态.
主要成果:
- BPTF knockdown 抑制了质瘤细胞的恶性行为,与 FOXC1 表达率下降相关.
- 在质瘤组织中,FOXC1被上调,这与晚期瘤阶段和更差的预后有关.
- 通过USP34介导的de-ubiquitylation,BPTF调节FOXC1的稳定性,影响着质瘤的进展.
结论:
- BPTF/FOXC1信号轴是质瘤发展的关键驱动因素.
- 准BPTF/FOXC1通路为质瘤抑制提供了一个潜在的治疗策略.
更多相关视频
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
11:46Investigating Protein-protein Interactions in Live Cells Using Bioluminescence Resonance Energy Transfer
Published on: May 26, 2014
相关概念视频
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway
